Alyne Baker
Overview
Explore the profile of Alyne Baker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Havens P, Stephensen C, Van Loan M, Schuster G, Woodhouse L, Flynn P, et al.
Clin Infect Dis
. 2017 Oct;
66(2):220-228.
PMID: 29020329
Background: Tenofovir disoproxil fumarate (TDF) decreases bone mineral density (BMD). We hypothesized that vitamin D3 (VITD3) would increase BMD in youth receiving TDF. Methods: This was a randomized, double-blind, placebo-controlled...
2.
Alexander A, Ott M, Lally M, Sniecinski K, Baker A, Zimet G
Vaccine
. 2015 Feb;
33(11):1331-7.
PMID: 25645175
Purpose: The purpose of this study was to examine the process of adolescent decision-making about participation in an HIV vaccine clinical trial, comparing it to adult models of informed consent...
3.
Havens P, Hazra R, Stephensen C, Kiser J, Flynn P, Wilson C, et al.
Antivir Ther
. 2014 Feb;
19(6):613-8.
PMID: 24535626
Background: Tenofovir (TDF) is associated with phosphaturia and elevated 1,25 dihydroxy vitamin D (1,25-OH(2)D). Fibroblast growth factor 23 (FGF23) causes phosphaturia and increases in response to elevated 1,25-OH(2)D. Vitamin D-binding...
4.
Havens P, Kiser J, Stephensen C, Hazra R, Flynn P, Wilson C, et al.
Antimicrob Agents Chemother
. 2013 Sep;
57(11):5619-28.
PMID: 24002093
Tenofovir disoproxil fumarate (TDF) causes bone, endocrine, and renal changes by an unknown mechanism(s). Data are limited on tenofovir pharmacokinetics and these effects. Using baseline data from a multicenter study...
5.
Havens P, Stephensen C, Hazra R, Flynn P, Wilson C, Rutledge B, et al.
Clin Infect Dis
. 2012 Jan;
54(7):1013-25.
PMID: 22267714
Background: The study goal was to determine the effect of vitamin D (VITD) supplementation on tubular reabsorption of phosphate (TRP), parathyroid hormone (PTH), bone alkaline phosphatase (BAP), and C-telopeptide (CTX)...